These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31312082)

  • 1. Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach.
    Agarwal G; Gupta S; Gabrani R; Gupta A; Chaudhary VK; Gupta V
    Bioinformation; 2019; 15(6):439-447. PubMed ID: 31312082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design.
    Battini L; Fidalgo DM; Álvarez DE; Bollini M
    ACS Infect Dis; 2021 Jun; 7(6):1503-1518. PubMed ID: 34048233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of small molecule protein-protein interaction inhibitors: targeting hotspot regions at the interface of MXRA8 and CHIKV envelope protein.
    Verma J; Subbarao N
    J Biomol Struct Dyn; 2023 May; 41(8):3349-3367. PubMed ID: 35272566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.
    Verma J; Hasan A; Sunil S; Subbarao N
    J Comput Aided Mol Des; 2022 Jul; 36(7):521-536. PubMed ID: 35789450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    J Virol; 2024 Jun; ():e0067924. PubMed ID: 38842335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC; White-Scholten L; Tas A; Hoornweg TE; Ferla S; Kovacikova K; Smit JM; Brancale A; Snijder EJ; van Hemert MJ
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32191995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Chikungunya Virus Entry: Alternatives for New Inhibitors in Drug Discovery.
    Silva LR; Rodrigues ÉEDS; Taniele-Silva J; Anderson L; Araújo-Júnior JX; Bassi ÊJ; Silva-Júnior EFD
    Curr Med Chem; 2022; 29(4):612-634. PubMed ID: 34165405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.
    Metz SW; Geertsema C; Martina BE; Andrade P; Heldens JG; van Oers MM; Goldbach RW; Vlak JM; Pijlman GP
    Virol J; 2011 Jul; 8():353. PubMed ID: 21762510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: in silico structural modeling, docking and molecular dynamic studies.
    Deeba F; Malik MZ; Naqvi IH; Haider MSH; Shafat Z; Sinha P; Ishrat R; Ahmed A; Parveen S
    Virusdisease; 2017 Mar; 28(1):39-49. PubMed ID: 28466054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
    Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
    Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
    Selvarajah S; Sexton NR; Kahle KM; Fong RH; Mattia KA; Gardner J; Lu K; Liss NM; Salvador B; Tucker DF; Barnes T; Mabila M; Zhou X; Rossini G; Rucker JB; Sanders DA; Suhrbier A; Sambri V; Michault A; Muench MO; Doranz BJ; Simmons G
    PLoS Negl Trop Dis; 2013; 7(9):e2423. PubMed ID: 24069479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking Studies to Explore Potential Binding Pockets and Inhibitors for Chikungunya Virus Envelope Glycoproteins.
    Nguyen PTV; Yu H; Keller PA
    Interdiscip Sci; 2018 Sep; 10(3):515-524. PubMed ID: 28283929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells.
    de Oliveira DM; Santos IA; Martins DOS; Gonçalves YG; Cardoso-Sousa L; Sabino-Silva R; Von Poelhsitz G; Franca EF; Nicolau-Junior N; Pacca CC; Merits A; Harris M; Jardim ACG
    Front Microbiol; 2020; 11():608924. PubMed ID: 33384677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Molecular Surveillance of Chikungunya Virus.
    Fischer C; de Lamballerie X; Drexler JF
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus.
    Cao L; Wang W; Sun W; Zhang J; Han J; Xie C; Ha Z; Xie Y; Zhang H; Jin N; Lu H
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.
    Mahish C; De S; Chatterjee S; Ghosh S; Keshry SS; Mukherjee T; Khamaru S; Tung KS; Subudhi BB; Chattopadhyay S; Chattopadhyay S
    Front Immunol; 2023; 14():1139808. PubMed ID: 37153546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
    Chua CL; Sam IC; Merits A; Chan YF
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.